Optimizing patient triage on the waiting list for transcatheter aortic valve replacement: the clinical utility of the cardiac damage staging system

European Heart Journal - Quality of Care and Clinical Outcomes 2026 Open access

Read full text
Authors: K. Boyer, Adrien Carmona, François Séverac, Antonin Trimaille, Kévin Roulot, Shinosuke Kikuchi, Marion Kibler, P Ohlmann, Benjamin Marchandot, O Morel
DOI: 10.1093/ehjqcco/qcag001
Cited by: 1
References: 30

Abstract

AIMS: Access to transcatheter aortic valve replacement (TAVR) is generally prioritized for symptomatic patients presenting with severe heart failure, syncope, angina, and decrease in left ventricular ejection fraction 60 mmHg [sHR, 2.37 (95% CI, 1.36-4.12); P = 0.002]. Généreux stages 3 and 4 showed a strong association with waiting-list mortality, more than doubling the risk of death [sHR, 2.12 (95% CI, 1.33-3.38); P = 0.002]. CONCLUSION: These findings suggest that TAVR candidates at Généreux stages 3 and 4 should receive higher priority on the waiting list.

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Mechanical Circulatory Support Devices Cardiac Structural Anomalies and Repair

Publication details

Journal / source
European Heart Journal - Quality of Care and Clinical Outcomes
Publisher
Oxford University Press (OUP)
Volume
12
Issue
4
Pages
484–493
Publication date
27 February 2026
Language
EN